SCOPUS 정보 검색 플랫폼

Drugs of the Future

Volumn 25, Issue 7, 2000, Pages 669-673

CDP-571. Treatment of IBD, anti-TNF-α MAb

(3) Sorbera, L A a Martin, L a Leeson, P A a

a PROUS SCIENCE (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALICAFORSEN; ANTIINFLAMMATORY AGENT; APC 2059; AZATHIOPRINE; AZATHIOPRINE DERIVATIVE; BALSALAZIDE; BAY 10 3356; BETA1A INTERFERON; BUDENOFALK; BUDESONIDE; CC 1088; CDC 801; CIPROFLOXACIN; ENTECORT; ETANERCEPT; HYDROCORTISONE; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; METRONIDAZOLE; NATALIZUMAB; ORAZIPONE; PENTOXIFYLLINE; PREDNISOLONE; RECOMBINANT INTERLEUKIN 10; RECOMBINANT INTERLEUKIN 11; SALAZOSULFAPYRIDINE; SI 3501; TACROLIMUS; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL TRIAL; CROHN DISEASE; DOSE RESPONSE; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG HALF LIFE; HUMAN; NONHUMAN; RECTUM HEMORRHAGE; RHEUMATOID ARTHRITIS; SIDE EFFECT; ULCERATIVE COLITIS;

EID: 0033805789 PISSN: 03778282 EISSN: None Source Type: Journal
DOI: 10.1358/dof.2000.025.07.585694 Document Type: Article

Times cited : (1)

References (17)

1
- 0007739799
- Recombinant antibodies specific for TNF-α. EP 0626389, JP 1998136986
- Adair, J.R.¹ Emtage, J.S.² Athwal, D.S.³ Bodmer, M.W.⁴

2
- 0007784384
- TNF antagonism: Clinical efficacy of anti-TNF antibodies in rheumatoid arthritis and Crohn's disease. IBC Int Conf Anti-Inflamm Drug Discov. Novel Approaches Ther Dev (Sept 30-Oct 2, Arlington) 1996
- (1996)
- Bloxham, D.P.¹

3
- 0033125226
- Antitumor necrosis factor therapy for inflammatory bowel disease: A review of agents, pharmacology, clinical results, and safety
- (1999) Inflamm Bowel Dis , vol.5 , pp. 119-133
- Sandborn, W.J.¹ Hanauer, S.B.²

4
- 0029853846
- Endogenous modulators of TNF and IL-1 response are under partial control of TNF in baboon bacteremia
- (1996) Am J Physiol , vol.271
- Redl, H.¹ Schlag, G.² Paul, E.³ Bahrami, S.⁴ Buurman, W.A.⁵ Strieter, R.M.⁶ Kunkel, S.L.⁷ Davies, J.⁸ Foulkes, R.⁹

5
- 0030834037
- Treatment of ulcerative colitis with an engineered human anti-TNFα antibody CDP571
- (1997) Aliment Pharmacol Ther , vol.11 , pp. 1031-1035
- Evans, R.C.¹ Clarke, L.² Heath, P.³ Stephens, S.⁴ Morris, A.I.⁵ Rhodes, J.M.⁶

6
- 4243747080
- Anti-TNFα treatment of a model of human ulcerative colitis
- (1994) Gut , vol.35 , Issue.SUPPL. 2
- Warren, B.F.¹

7
- 0007741427
- Early clinical experience with CDP571, an engineered human anti-TNFα antibody, in ulcerative colitis and Crohn's disease. IBC Conf Dev Novel Anti-Inflamm Ther Inflamm Bowel Dis (June 3-4, Philadelphia) 1996
- (1996)
- Heath, P.K.¹

8
- 0033034941
- Combination therapy of pentoxifylline and TNFα monoclonal antibody in dextran sulphate-induced mouse colitis
- (1999) Aliment Pharmacol Ther , vol.13 , pp. 251-260
- Murthy, S.¹ Cooper, H.S.² Yoshitake, H.³ Meyer, C.⁴ Meyer, C.J.⁵ Murthy, N.S.⁶

9
- 0029162562
- Comprehensive pharmacokinetics of a humanized antibody and analysis of residual anti-idiotypic responses
- (1995) Immunology , vol.85 , pp. 668-674
- Stephens, S.¹ Emtage, S.² Vetterlein, O.³ Chaplin, L.⁴ Bebbington, C.⁵ Nesbitt, A.⁶ Sopwith, M.⁷ Athwal, D.⁸ Novak, C.⁹ Bodmer, M.¹⁰

10
- 0031043778
- Randomised controlled trial of CDP571 antibody to tumour necrosis factor-α in Crohn's disease
- (1997) Lancet , vol.349 , pp. 521-524
- Stack, W.A.¹ Mann, S.D.² Roy, A.J.³

11
- 0034635834
- Antibodies to tumour necrosis factor α as treatment for Crohn's disease
- (2000) Lancet , vol.355 , pp. 858-860
- Bell, S.¹ Kamm, M.A.²

12
- 0000047257
- A randomized controlled trial of CDP571, a humanized antibody to TNFalpha, in moderately to severely active Crohn's disease
- (2000) Gastroenterology , vol.118 , Issue.4 SUPPL. 2 PART 1
- Sandborn, W.J.¹ Targan, S.R.² Hanauer, S.B.³

13
- 0001349673
- A randomized, double-blind, placebo-controlled, multi-center trial of the engineered human antibody to TNF (CDP571) for induction and maintenance of clinical improvement in patients with moderate to severely active Crohn's disease
- Abst P0235
- (1999) Gut , vol.45 , Issue.SUPPL. 5
- Sandborn, W.J.¹ Targan, S.R.² Wolf, D.C.³

14
- 0000047257
- A randomized, double-blind, placebo-controlled, multi-center trial of the engineered human antibody to TNF (CDP571) for steroid sparing and maintenance of remission in patients with steroid-dependent Crohn's disease
- (2000) Gastroenterology , vol.118 , Issue.4 SUPPL. 2 PART 1
- Feagan, B.G.¹ Sandborn, W.J.² Baker, J.P.³

15
- 0000446683
- A randomized, double-blind, placebo-controlled, multi-center trial of the engineered human antibody to TNF (CDP571) for steroid sparing and maintenance of remission in patients with steroid-dependent Crohn's disease
- Abst P0228
- (1999) Gut , vol.45 , Issue.SUPPL. 5
- Feagan, B.G.¹ Sandborn, W.J.² Baker, J.P.³

16
- 0029044028
- The therapeutic effects of an engineered human anti-tumour necrosis factor alpha antibody (CDP571) in rheumatoid arthritis
- (1995) Br J Rheumatol , vol.34 , pp. 334-342
- Rankin, E.C.C.¹ Choy, E.H.² Kassimos, D.³ Kingsley, G.H.⁴ Sopwith, A.M.⁵ Isenberg, D.A.⁶ Panayi, G.S.⁷

17
- 0007834752
- Celltech Group plc Annual General Meeting. Celltech Group plc Press Release May 25, 2000
- (2000)

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.